These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 20308688
1. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Nardin R. Neurology; 2010 Mar 23; 74(12):1007; author reply 1007-8. PubMed ID: 20308688 [No Abstract] [Full Text] [Related]
4. Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. Connor KM, Aurora SK, Loeys T, Ashina M, Jones C, Giezek H, Massaad R, Williams-Diaz A, Lines C, Ho TW. Headache; 2011 Jan 23; 51(1):73-84. PubMed ID: 21070230 [Abstract] [Full Text] [Related]
6. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine. Tepper SJ, Cleves C. Curr Opin Investig Drugs; 2009 Jul 23; 10(7):711-20. PubMed ID: 19579177 [Abstract] [Full Text] [Related]
7. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK. Lancet; 2008 Dec 20; 372(9656):2115-23. PubMed ID: 19036425 [Abstract] [Full Text] [Related]
8. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease. Ho TW, Ho AP, Chaitman BR, Johnson C, Mathew NT, Kost J, Fan X, Aurora SK, Brandes JL, Fei K, Beebe L, Lines C, Krucoff MW. Headache; 2012 Feb 20; 52(2):224-35. PubMed ID: 22221076 [Abstract] [Full Text] [Related]
9. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Edvinsson L, Linde M. Lancet; 2010 Aug 21; 376(9741):645-55. PubMed ID: 20416945 [Abstract] [Full Text] [Related]
10. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D. Neurology; 2014 Sep 09; 83(11):958-66. PubMed ID: 25107879 [Abstract] [Full Text] [Related]
17. A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina. Chaitman BR, Ho AP, Behm MO, Rowe JF, Palcza JS, Laethem T, Heirman I, Panebianco DL, Kobalava Z, Martsevich SY, Free AL, Bittar N, Chrysant SG, Ho TW, Chodakewitz JA, Murphy MG, Blanchard RL. Clin Pharmacol Ther; 2012 Mar 09; 91(3):459-66. PubMed ID: 22278333 [Abstract] [Full Text] [Related]
19. [CGRP antagonists: novel concept for treatment of migraine]. Nieber K. Med Monatsschr Pharm; 2009 May 20; 32(5):182-5. PubMed ID: 19469188 [Abstract] [Full Text] [Related]